Abstract
Radiolabeling of fullerol, 125I–C60(OH) x , was performed by the traditional chloramine-T method. The C–I covalent bond in I–C60(OH) x was characterized by X-ray photoelectron spectroscopy (XPS) that was sufficiently stable for in vivo study. Laser light scattering spectroscopy clearly showed that C60(OH) x aggregated to large nanoparticle clumps with a wide range of distribution. The clumps formed were also visualized by transmission electron microscope (TEM). We examined the biodistribution and tumor uptake of C60(OH) x in five mouse bearing tumor models, including mouse H22 hepatocarcinoma, human lung giantcellcarcinoma PD, human colon cancer HCT-8, human gastric cancer MGC803, and human OS732 osteosarcoma. The accumulation ratios of 125I–C60(OH) x in mouse H22 hepatocarcinoma to that in normal muscle tissue (T/N) and blood (T/B) at 1, 6, 24 and 72 h, reveal that 125I–C60(OH) x gradually accumulates in H22 tumor, and retains for a quite long period (e.g., T/N 3.41, T/B 3.94 at 24 h). For the other four tumor models, the T/N ratio at 24 h ranges within 1.21–6.26, while the T/B ratio ranges between 1.23 and 4.73. The accumulation of C60(OH) x in tumor is mostly due to the enhanced permeability and retention effect (EPR) and the phagocytosis of mononuclear phagocytes. Hence, C60(OH) x might serve as a photosensitizer in the photodynamic therapy of some kinds of tumor.
Similar content being viewed by others
References
Bernstein R., Prat F., Foote C.S. (1999) On the mechanism of DNA cleavage by fullerenes investigated in model systems: electron transfer from guanosine and 8-oxo-guanosine derivatives to C60. J. Am. Chem. Soc. 121: 464–465
Bianco A., Maggini M., Scorrano G., Toniolo C., Marconi G., Villani C., Prato M. (1996) Synthesis, chiroptical properties, and configurational assignment of fulleroproline derivatives and peptides. J. Am. Chem. Soc. 118: 4072–4080
Brettreich M., Hirsch A. (1998) A highly water-soluble dendro[60]fullerene. Tetrahedron Lett. 39: 2731–2734
Brigger I., Dubernet C., Couvreur P. (2002) Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliver. Rev. 54: 631–651
Bullard-Dillard R., Creek K.E., Scrivens W.A., Tour J.M. (1996) Tissue sites of uptake of 14C-labeled C60. Bioorg. Chem. 24: 376–385
Burley, G.A., Keller, P.A., Pyne, S.G. & G.E. Ball, 1998. Synthesis of a 1,2-dihydro[60]fullerylglycine derivative by a novel cyclopropane ring opening of a methano[60]fullerene. Chem. Commun., 2539–2540
Cagle D.W., Kennel S.J., Mirzadeh S., Alford J.M., Wilson L.J. (1999) In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc. Natl. Acad. Sci. USA 96: 5182–5187
Chen Y., Cai R.F., Chen S.M., Huang Z.E. (2001) Synthesis and characterization of fullerol derived from C60(n−) precursors. J. Phys. Chem. Solids 62: 999–1001
Cusan, C., Da Ros, T. Spalluto, G., Foley, S., Janot, J.M., Seta, P., Larroque, C., Tomasini, M.C., Antonelli, T., Ferraro, L. & M. Prato, 2002. A new multi-charged C60 derivative: synthesis and biological properties. Eur. J. Org. Chem., 2928–2934
Dugan L.L., Gabrielsen J.K., Yu S.P., Lin T.S., Choi D.W. (1996) Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 3: 129–135
Friedman S.H., DeCamp D.L., Sijbesma R.P., Srdanov G., Wudl F., Kenyon G.L. (1993) Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J. Am. Chem. Soc. 115: 6506–6509
Guldi D.M., Asmus K.D. (1999) Activity of water-soluble fullerenes towards (OH)-O-center dot-radicals and molecular oxygen. Radiat. Phys. Chem. 56: 449–456
Hirsch A., Lamparth I., Grösser T. (1994) Regiochemistry of multiple additions to the fullerene core: Synthesis of a th-symmetric hexakis adduct of C60 with bis(ethoxycarbonyl)methylene. J. Am. Chem. Soc. 116: 9385–9386
Hobbs S., Monsky W.L., Yuan F., Robersts W.G., Griffith L., Torchilin V.P., Jain R.K. (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenviroment. Proc. Natl. Acad. Sci. USA 95: 4607–4612
Hsu S.C., Wu C.C., Luh T.Y., Chou C.K., Han S.H., Lai M.Z. (1998) Apoptotic signal of Fas is not mediated by ceramide. Blood 91: 2658–2663
Kim S.H., Son H., Nam G., Chi D.Y., Kim J.H. (2000) Synthesis and in vitro antibacterial activity of 3-[N-methyl-N-(3-methyl-1,3-thiazolium-2-yl)amino]methyl cephalosporin derivatives. Bioorg. Med. Chem. Lett. 10: 1143–1145
Krätschemer W., Lamb L.D., Fostiropoulos K., Huffman (1990) Solid C60: a new form of carbon. Nature 347: 354–358
Krstic J.S. (1997) Effects of C60(OH)24 on microtubule assembly. Arch. Oncol. 5: 143–147
Li, J., Takeuchi, A., Ozawa, M., Li, X.H., Saigo, K. & K. Kitazawa, 1993. C60 fullerol formation catalyzed by quaternary ammonium hydroxides. J. Chem. Soc. Chem. Commun., 1784–1785
Li Q.N., Xiu Y., Zhang X.D., Liu R.L., Du Q.Q., Shun X.Q., Chen S.L., Li W.X. (2002) Preparation of 99 mTc-C60(OH)x and its biodistribution studies. Nucl. Med. Biol. 29: 707–710
Maeda H. (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41: 189–207
Matsumura Y., Maeda H. (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46: 6387–6392
Satoh M., Matsuo K., Kiriya H., Mashino T., Nagano T., Hirobe M., Takayanagi I. (1997) Inhibitory effects of a fullerene derivative, dimalonic acid C60, on nitric oxide-induced relaxation of rabbit aorta. Eur. J. Pharmacol. 327: 175–181
Tabata Y., Ikada Y. (1999) Biological functions of fullerene. Pure & Appl. Chem. 71: 2047–2053
Tokuyama H., Yamago S., Nakamura E., Shiraki T., Sugiura Y. (1993) Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc. 115: 7918–7919
Ueng T.H., Kang J.J., Wang H.W., Cheng Y.W., Chiang L.Y. (1997) Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60. Toxicol. Lett. 93: 29–37
Wang I.C., Tai L.A., Lee D.D., Kanakamma P.P., Shen C.K.F., Luh T.Y., Chen C.H., Hwang K.C. (1999) C60 and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. J. Med. Chem. 42: 4614–4620
Wang H.F., Wang J., Deng X.Y., Sun H.F., Shi Z.J., Gu Z.N., Liu Y.F., Zhao Y.L. (2004) Biodistribution of carbon single-wall nanotubes in mice. J. Nanosci. Nanotech. 4(8): 1–6
Acknowledgements
We thank the support from the National Natural Science Foundation of China (Grant No. 10490180 and 90406024-5). And we thank Dr. YiQun Gu for her help in the pathology analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ji, Z., Sun, H., Wang, H. et al. Biodistribution and tumor uptake of C60(OH) x in mice. J Nanopart Res 8, 53–63 (2006). https://doi.org/10.1007/s11051-005-9001-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11051-005-9001-5